97. The table below compares many ETF metrics between IBB and XBI. View Holdings As of 09/30/2023. Price Chart. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. In contrast, most. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 50. ETFs are subject to market fluctuation and the risks of their underlying investments. XBI: Head-To-Head ETF Comparison. The top holdings of these ETFs are Exact Sciences Corp. A few losers won't cause XBI to crash. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Rated on Jun 30, 2023 Published on Jun 30. Top 10 Holdings. As a result, the ETF reached a new 8-month low. The ETF has lost about -12. 60 as the 52 week high point — that compares with a last trade of $77. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. Brazil. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Advertisement. 33% from the latest price. It can be found in the fund’s most recent prospectus. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. 76% allocation. Shares of XBI stock opened at $73. 58% and is down about -14. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. SPDR® S&P Biotech ETF. Performance and Risk. Holdings. XBI has a higher expense ratio than XLV (0. Holdings Details. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. Per cent of portfolio in top 5 holdings: 8. The following charts reflect the allocation of WCLD's underlying. Top Holdings . 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. Sector Exposure and Top Holdings. 40. Both IBB and XBI have a similar number of assets under management. 18. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 98 and standard deviation of 40. As of 9/30/23. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. View complete WCLD exchange traded fund holdings for better informed ETF trading. Stock Analysis Chart Headlines Holdings Ownership Ratings. Across the 192 current stocks in the fund, all holdings have a weighting between 0. In seeking to track the performance of the S&P Biotechnology Select. 31 per share, with $92. 15 per share, with $174. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. argenx SE ADR. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. The gross expense ratio is the fund’s total annual operating expenses ratio. 85. Both XBI and XLV are ETFs. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). 1. 1% over the past year to close the last trading session at $81. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. 11. 26 during this last 52-week period. XBI has traded between $62. ETF Report Card. 8% of its total assets under management. 19%. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Message board - Online Community of active, educated investors researching and discussing Alaunos Therapeutics, Inc. Oct 10, 2022 01:14PM EDT. FA Report PDF. SGEN. Holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. 74. 78% of XBI's total assets under management. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. Below is the comparison between BBC and XBI. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 64 per share, with $174. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 67. Like IBB, XBI uses diversification to. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. com. XBI has traded between $73. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. Taking a look at the XBI, it peaked at $174. LABD. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 54%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). 2014. Lens & Shutter Holdings Ltd. Reply Like (7) q. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 12% in the last one year (as. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Top 10 Holdings (14. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Currency in USD. 70% so far this year and is down about -16. 35% ; Sectors:. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. Both BBH and XBI are ETFs. 38% vs. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 9. 9%: Israel: 3. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 66 +2. SPDR S&P Biotech ETF ETF holdings by MarketWatch. 0. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. VHT has a higher 5-year return than XBI (7. 01%). XBI has a Diversified Portfolio. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 37% in the last one. Mon, Oct 30, 12:50 PM ET, Market News Video. News & World Report, XBI enjoys volume of 20. Net expense ratio. According to data from U. Better trading starts here. Holdings. It has a total of 153 holdings. 3. Both VHT and XBI are ETFs. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. MTD. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. 81. The split for XBI took place on September 11, 2015. 67% Symbol Company Name Industry Percent of Assets MRTX Mirati Therapeutics Inc Biotechnology 2. Vertex Pharmaceuticals (VRTX 0. 60 as the 52 week high point — that compares with a last trade of $69. There is no guarantee the funds will achieve their stated investment objectives. The latter proposal about IBB determines its main difference from XBI - the former is more focused on the large biotech companies (the share of Amgen Inc. 03 per $1,000 of principal). ARGX. The top holding in XBI receives just a 1. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. The top 10 holdings account for about 14. ETF Strategies. com Ltd. Free ratings, analyses, holdings, benchmarks, quotes, and news. 5. Looking at the chart above, XBI's low point in its 52 week range is $100. 47% vs -5. Performance and Risk. 27%. 47 million over the past three months. 88%. large-cap stocks. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Looking at the chart above, XBI's low point in its 52 week range is $62. Seeks to track a modified. N/A. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The famed investor's Berkshire Hathaway (. Discover historical prices for XBI stock on Yahoo Finance. ( AMGN) = 9. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. $0. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. 96%, and is down about -5. N/A. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. 35% for XBI, but SBIO yields 2. With XBI trading at a recent price near $131. 97. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. S. 28% so far this year and in the past one. For an investor to take. 2. Both BBC and XBI are ETFs. Looking at the chart above, XBI's low point in its 52 week range is $97. There is no guarantee the fund will achieve its stated investment objective. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 84. 0. 2013. 71% of total assets under management. LABU. $156. 2013. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. XBI vs ARKG. Meanwhile, XBI equal weights its holdings. Holdings AS OF 04/30/2023. 7% of assets. XBI, HZNP, BIIB, VCYT: ETF Outflow Alert. 2 %. 2. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. 97. November 03, 2023 — 10:50 am EDT. It is gross of any fee waivers or expense reimbursements. Top 10 Holdings. XBI. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Below is the comparison between ARKG and XBI. It's trading down (17%) versus LABU, down (68%) in one-year performance. 45% and is down about -9. Overview. 35%). 10% of. 56% vs 0. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. Follow. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. 67. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. Visitors trend 2W 10W 9M. 2, 2023. 39. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). Summary. 96%, and is down about -5. Implied XBI Analyst Target Price: $135. Analyst Forecast. Real Estate ETFs. 80% of total assets under management. •. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. 84. 12% in the. But that definitely wasn't the case recently. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. While I love Cathie Wood, I just don't see how she can keep this up. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. The most heavily invested institutionals were Morgan Stanley ($614. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. XBI's 120. Free ratings, analyses, holdings, benchmarks, quotes, and news. Additionally. XBI - SPDR (R) S&P (R) Biotech ETFs top. Both LABU and XBI are ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1% over the past year to close the last trading session at $81. Performance and Risk. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI has a beta of 1. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Mirati. Neena Mishra May 10, 2023. XBI vs BBH. 94 per share, with $116. S. In addition to holding 155 positions, its top 10 holdings make up just 14. 73. Rated on Jun 30, 2023 Published on Jun 30. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Over a longer time than that, it has no top holdings. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. Looking at the chart above, XBI's low point in its 52 week range is $100. Looking at the chart above, XBI's low point in its 52 week range is $61. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. Performance and Risk. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 27. 12 and $91. Mirati Therapeutics. 73% so far this year and is down about -39. Fidelity does not endorse or adopt their content. 2. 20 -4. 18. Top 10 Holdings 16. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Components of. 8% of its total assets under management. 50% vs. View complete XLP exchange traded fund holdings for better informed ETF trading. The 10 largest holdings have a combined 17. 5x and PE ratio is about 14x. XBI's top 10 holdings account for about 11. In addition to holding 155 positions, its top 10. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. XBI has traded between $62. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. -listed equities in the biotechnology sector. We have highlighted five ETFs from different. 2% Top Ten Holdings. Its top 10 holdings account for approximately 16. View Holdings As of 09/30/2023. Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing. 86% so far this year and is down about -32. Summary. Research performance, expense ratio, holdings, and volatility to see if it's the. . 97. Total net assets. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Comparing XBI with other biotech ETFs, we note that XBI is one of the largest with around US$8 billion in assets under management and has one of the lowest expense ratios at 0. Veeva Systems. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. Top 10 Holdings XBI. Performance and Risk. XBI Description. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. Discover historical prices for XBI stock on Yahoo Finance. And, again, it is in the top 15 holdings by weighting of the. 58%). SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Holdings. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. Looking at the chart above, XBI's low point in its 52 week range is $72. 52 (-1. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. Front end load. 264,458,476. Free ratings, analyses, holdings, benchmarks, quotes, and news. Assets Under Management. 7% vs -5. Better trading starts here. 🇺🇸. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 003 on 06/20/23 ; Management Fee 0. 08%. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 91 (11/14/23) 1 Day XBI 0. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. Royal Gold Inc. 15 billion. Complete SPDR S&P Biotech ETF funds overview by Barron's. 79 as the 52 week high point — that compares with a last trade of $116. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 80 per share, with $92. All 142 XBI Holdings. TG Therapeutics Inc TGTX:US. 2401 Millstream Rd 125 Victoria BC. 16bn USD. 16bn USD.